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Cardiac Output Is Not Related to the Slowed
O2 Uptake Kinetics in Type 2 Diabetes
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ABSTRACT
MACANANEY, O., J. MALONE, S. WARMINGTON, D. O’SHEA, S. GREEN, and M. EGAN˜A. Cardiac Output Is Not Related to the
Slowed O2 Uptake Kinetics in Type 2 Diabetes.Med. Sci. Sports Exerc., Vol. 43, No. 6, pp. 935–942, 2011. Purpose: This study aimed
to investigate whether cardiac output (CO) responses were related to V˙O2 kinetics during cycling in type 2 diabetes.Methods: A total of
9 middle-aged women with uncomplicated type 2 diabetes, 9 nondiabetic overweight women, and 11 nondiabetic lean women were
recruited. Initially, the ventilatory threshold (VT) and peak V˙O2 were determined during a maximal graded test. Then, on two separate
days, subjects completed three 7-min bouts of constant-load cycling at each of three intensities: 50% VT, 80% VT, and midpoint between
VT and peak V˙O2 (50% $). CO (inert gas rebreathing) was recorded at 30 and 240 s of an additional bout at each intensity. V˙O2 kinetic
parameters were determined by fitting a biexponential (50% VT and 80% VT) or triexponential (50% $) function to the V˙O2 data.
Results: Peak V˙O2 was significantly lower in type 2 diabetes compared with the two nondiabetic groups (P G 0.05). The time constant of
phase 2 was significantly greater (P G 0.05) in type 2 diabetes compared with the nondiabetic heavy and lean groups at 50% VT (34.2 T
15.7 vs 15.4 T 7.3 and 20.2 T 9.7 s) and 80% VT (39.1 T 9.0 vs 24.8 T 8.8 and 36.8 T 7.9 s), but none of the V˙O2 kinetic parameters were
different at 50% $. CO responses during exercise were not different among the three groups, and at 80% VT, the change in CO from 30
to 240 s was significantly larger in type 2 diabetes compared with the two nondiabetic groups. Conclusions: The results confirm that type
2 diabetes slows the dynamic response of V˙O2 during light and moderate relative intensity exercise in females but that this occurs in the
absence of any slowing of the CO response during the initial period of exercise. Key Words: CARDIAC OUTPUT, O2 UPTAKE
KINETICS, TYPE 2 DIABETES, WOMEN, CYCLING
S
ubjects with type 2 diabetes exhibit exercise intoler-
ance (2,20,23,25) that is associated with an increased
risk of mortality (30). The cause of exercise intoler-
ance in diabetes is not well understood, but peak oxygen
uptake (V˙O2) has consistently been shown to be reduced
in type 2 diabetic subjects compared with healthy control
subjects matched for age, weight, and activity levels
(2,18,23–25,28). In addition, pulmonary V˙O2 has been re-
ported to adjust more slowly during the early period of
exercise (i.e., slower V˙O2 kinetics) in type 2 diabetes com-
pared with nondiabetic controls during submaximal cycling
exercise (4,7,23).
Slowing of the dynamic response of V˙O2 during submax-
imal exercise might increase fatigue and contribute to exer-
cise intolerance (13). The control of V˙O2 during the initial
period of exercise depends on the control of blood flow (O2
delivery) to, and control of O2 consumption by, the con-
tracting muscles. To our knowledge, there are no data on the
dynamic response of either cardiac output (CO) or muscle
blood flow during exercise in humans with type 2 diabetes. In
streptozodocin-induced rats (a type 2 diabetes model), the
decline in muscle microvascular PO2 observed during the first
60 s of intermittent contractions (1 Hz) was more rapid than
in control animals (6). Similarly, the near-infrared spectros-
copy (NIRS)–measured concentrations of oxygenated and
deoxygenated hemoglobin/myoglobin ([HHb]) of the thigh
muscle showed a transient ‘‘overshoot’’ at the onset of mod-
erate cycling exercise above the level achieved for steady
state in humans with type 2 diabetes but not in healthy con-
trols (4). In the same study, the microvascular blood flow
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responses, estimated from simultaneously measured NIRS-
derived [HHb] signals and pulmonary V˙O2 responses, were
significantly slower in subjects with type 2 diabetes compared
with healthy controls (4). Both of these observations (4,6)
suggest that the rate of O2 delivery is slowed relative to
the rate of O2 consumption by contracting muscle in type
2 diabetes.
Steady-state measurements provide a more conflicting
picture of this problem. Lower limb blood flow measured
after several minutes of submaximal cycling was blunted in
subjects with type 2 diabetes (17). In contrast, both CO and
arteriovenous O2 difference (a-v O2) measured after 5 min of
submaximal cycling were similar between diabetic subjects
and healthy controls (2). However, none of these findings
shed light on the rate of cardiovascular adjustments before
the achievement of a steady state. To explore this further, the
aim of the present study was to test the hypothesis that the
dynamic responses of CO and oxygen uptake are slowed in
type 2 diabetes. Because the effect of type 2 diabetes on V˙O2
kinetics might depend on the intensity of exercise (4,7,23),
this hypothesis was tested at three submaximal workloads.
METHODS
Subjects. Unless otherwise stated, all experimental pro-
cedures were completed within the Department of Physiol-
ogy, Trinity College Dublin, after approval by the Faculty of
Health Sciences Research Ethics Committee in accordance
with the Declaration of Helsinki. After providing written
informed consent, 29 female subjects were recruited into
the following three groups according to specific inclusion/
exclusion criteria: patients being treated for type 2 diabetes
mellitus (n = 9); overweight but otherwise healthy controls
(‘‘heavy controls,’’ n = 9); and lean and healthy controls
(‘‘lean controls,’’ n = 11; Table 1).
Subjects with type 2 diabetes were recruited in consulta-
tion with, and were all receiving treatment for diabetes at,
St. Columcilles Hospital, Dublin. Healthy subjects were re-
cruited from Trinity College Dublin. All subjects were free
of signs, symptoms, and clinical evidence of coronary or
peripheral arterial disease, neuropathy, or retinopathy. They
were nonsmokers and had not smoked during the 12-month
period preceding the study. None of the subjects were taking
insulin, A-blockers, calcium channel blockers, or any other
antihypertensive drugs. None of the control subjects were
on prescriptive medication. However, diabetic subjects were
taking oral hypoglycemic prescription drugs (metformin,
n = 5; rosiglitazone, n = 1), statins (n = 3), and an angiotensin-
converting enzyme inhibitor (n = 1) and/or were undergoing
dietary control of their diabetes. All diabetic subjects had a
clinical history of diabetes of 1–5 yr. They were prescreened
by the treating physicians to confirm that blood pressure was
normal and that there was no kidney dysfunction (consistent
urinary protein G 200 mgIdLj1) or liver dysfunction (urinary
creatinine levels G 2.2 mgIdLj1). In addition, there was no
clinical evidence of ischemic heart disease based on a 12-lead
EKG response during a standard treadmill stress test.
All subjects were sedentary (G1 hIwkj1 of moderate-
intensity exercise) for at least 3 months before the study, and
this was confirmed after completion of the Low-Level Phys-
ical Activity Recall questionnaire (19,26). Subjects were re-
quired to refrain from taking alcohol, caffeine, and exercise
in the 12 h preceding each testing session (see below).
Experimental protocol. Each subject attended the
laboratory on three separate days for testing. Given that
some subjects were premenopausal (n = 11: 4 diabetic, 4
heavy controls, and 3 lean controls), testing sessions for all
subjects were separated by between 48 and 72 h to complete
all testing within 8 d, and this was aligned with the mid-
follicular phase of the menstrual cycle (days 5–12) for the
premenopausal subjects. None of the subjects were taking
contraceptive drugs or receiving hormone replacement ther-
apy during or 6 months before the testing period.
On all testing days, exercise was performed on an elec-
trically braked cycle ergometer (Excalibur Sport; Lode,
Groningen, The Netherlands). Subjects wore an HR monitor
(S725x; Polar Electro Oy, Kempele, Finland) to continu-
ously record HR every 5 s at rest and during exercise. In
addition, subjects wore a silicon facemask (7900 series; Hans
Rudolph, Kansas City, MO) for continuous analysis of ex-
pired gases on a breath-by-breath basis using an online met-
abolic system (Innocor; Innovision A/S, Odense, Denmark).
Analysis of expired air allowed determination of oxygen
uptake (V˙O2), carbon dioxide production (V˙CO2), minute
ventilation (V˙E), and the RER during all rest and exercise
periods. This system also enabled the measurement of CO
at specific time points via a rebreathing technique (see below
for description).
On testing day 1, subjects completed a graded cycle test
to fatigue. After 3 min of rest, subjects cycled at an initial
workload of 40 W for 3 min before the workload was in-
creased by 20 W every 3 min until a cadence of 60 rpm
could not be maintained (i.e., task failure). The peak work-
load achieved was defined as the highest workload able to
be maintained for at least 1 min. From this test, the work-
load at which the ventilatory threshold (VT) occurred was
determined using the V slope method by identifying the
power output at which a clear steeper increase of V˙CO2 as
compared with V˙O2 occurs (1,5).
On testing days 2 and 3, subjects were required to com-
plete six 7-min exercise bouts on each day, so that during the
TABLE 1. Mean (TSD) physical and hematological characteristics for the three groups
of subjects.
Type 2 Diabetes Heavy Controls Lean Controls
Age (yr) 49.1 T 5.7 42.5 T 12.6 44.1 T 8.2
Height (cm) 165 T 7 162 T 8 165 T 10
Body mass (kg) 94.0 T 22.8* 77.4 T 8.7* 63.6 T 16.7
BMI (kgImj2) 34.4 T 7.4* 29.0 T 8.7* 22.7 T 1.2
Glucose (mmolILj1) 8.1 T 1.7*,** 5.5 T 0.4 4.6 T 0.5
HbA1c (%) 6.8 T 1.0*
,** 5.1 T 0.4 5.3 T 0.3
Insulin (mUILj1) 12.3 T 4.8* 8.3 T 1.0 6.8 T 1.5
* Significantly different (P G 0.05) from the lean group.
** Significantly different (P G 0.05) from the heavy group.
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2 d, each subject completed four exercise bouts at each of the
following three intensities relative to the workloads achieved
at VT and peak V˙O2 as defined by the graded test performed
on day 1:50% VT, 80% VT, and midpoint between VT and
peak workload (50% $). Exercise bouts were completed in
a sequence of three, beginning with 3-min rest followed by
7-min cycling at 50% VT, then 10-min rest followed by 7-min
cycling at 80% VT, then 15-min rest followed by 7-min
cycling at 50% $. Subjects then rested for 45 min, after
which the exercise sequence was repeated. The entire session
(i.e., six bouts) was then replicated on testing day 3. Previous
data suggest the rest periods used are sufficient for HR and
blood lactate to return to resting levels (3,8,31).
The initial three bouts at each of the three intensities were
used to determine oxygen uptake kinetics, and the fourth
bout at each intensity was used for determination of CO
responses (see below).
Oxygen uptake and HR kinetics. Kinetics of oxy-
gen uptake were determined for each constant-load exercise
intensity using the breath-by-breath V˙O2 data collected dur-
ing the first three 7-min exercising periods at each intensity.
Data were linearly interpolated to 1-s intervals, time aligned
to the onset of exercise, and then an average data set deter-
mined for each subject at each intensity. The data set was
then smoothed using a 5-s moving average filter. Kinetic
parameters were determined by fitting a two-component ex-
ponential curve to the results for the exercise intensities
below the ventilatory threshold (50% VT and 80% VT; see
equation 1) while fitting a three-component exponential curve
to the results for the exercise intensity above the ventilatory
threshold (50% $; see equation 2).
V
q
O2 tð Þ ¼ baselineV
q
O2 þ A1 1 e tTD1ð Þ=T1
 
U1
þ A2 1 e tTD2ð Þ=T2
 
U2 ½1
V
q
O2 tð Þ ¼ baselineV
q
O2 þ A1 1 e tTD1ð Þ=T1
 
U1
þ A2 1 e tTD2ð Þ=T2
 
U2 þ A3 1 e tTD3ð Þ=T3
 
U3 ½2
The three exponential terms represent the ‘‘cardiodynamic,’’
‘‘fast,’’ and ‘‘slow’’ components of the V˙O2 response to ex-
ercise. Baseline V˙O2 represents oxygen uptake during the
initial 3-min rest period of each exercise bout; and for each
exponential term, A1, A2, and A3 are the asymptotic am-
plitudes; T1, T2, and T3 are the time constants; and TD1, TD2,
and TD3 are the time delays. The parameters U1, U2, and U3
are conditional expressions that limit the fitting of a partic-
ular phase to the period at and beyond the time delay asso-
ciated with that phase. The models were fitted to the data
using a weighted least-squares nonlinear regression procedure
(TableCurve 2D; Systat, Chicago, IL). Data that exceeded the
95% prediction intervals during an initial fit of a model were
excluded. The investigator who performed the curve fitting
procedure was blinded with respect to patient identification.
The mean response time (MRT) that represents the time to
reach 63% of the overall amplitude of the response from
baseline was calculated as a weighted sum of the time delay
and time constant of each phase. The equation used for 50%
VT and 80% VT can be seen below (equation 3):
MRT ¼ A1= A1 þ A2ð Þ TD1 þ T1ð Þ½  þ A2= A1 þ A2ð Þ TD2 þ T2ð Þ½  ½3
For 50% $ MRT was calculated as follows (equation 4):
MRT ¼ A1= A1 þ A2 þ A3ð Þ TD1 þ T1ð Þ½ 
þ A2= A1 þ A2 þ A3ð Þ TD2 þ T2ð Þ½ 
þ A3= A1 þ A2 þ A3ð Þ TD3 þ T3ð Þ½  ½4
HR was measured at rest and every 5 s during each of the
three constant-load cycling exercise trials at each intensity
and averaged to yield a single time series of HR data for each
subject at each intensity. The dynamic structures of the HR
responses were not as consistent between subjects as the
oxygen uptake responses, so a relatively simpler, monoexpo-
nential function was chosen to fit HR responses (equation 5),
heart rate ¼ aþ A 1 e tTDð Þ=T
 
½5
where a is the baseline HR, A is the amplitude of the exer-
cise response, TD is the delay in rise of HR after exercise
onset, and T is the time constant of the response. The fitting
procedures were identical with that described for oxygen
uptake.
CO. CO was measured using an inert gas (sulfur hexa-
fluoride (SF6) and nitrous oxide (N2O)) rebreathing tech-
nique based on the Fick principle, as previously described
(14). This was performed during the final exercise bout only
on testing day 3, but at two time points (at 30 and 240 s)
during each 7-min exercise period at each intensity. In brief,
subjects were required to initially inspire an entire bolus
volume (40% predicted vital capacity) of the test gas mixture
contained within a rubber bag connected to the Innocor res-
piratory valve assembly. A preset respiratory rate (20 breaths
per minute) was required to be maintained in synchrony with
the visual display on the Innocor screen during continuous
rebreathing with the rubber bag until equilibration of gas
concentrations was apparent. This usually occurred within
four to five breaths (approximately 15–20 s). From each ma-
neuver, pulmonary blood flow (CO) was determined, and in
conjunction with the continuous HR record, stroke volume
(SV) was calculated (CO/HR). The a-v O2 difference was
calculated as V˙O2/CO. Recent unpublished data from our
laboratory revealed that the device provides highly repro-
ducible responses when the same subjects (both subjects with
diabetes n = 7 and subjects without diabetes n = 10) perform
the same CO measurements at 30 and 240 s during three
exercise bouts (at 50% VT, 80% VT, and 50% $) completed
on two to three occasions (coefficient of variation ~5%).
Before the exercise on testing day 3, subjects were famil-
iarized with the rebreathing technique by completing the
maneuver up to 5 times in ‘‘demo’’ mode, which simulates the
rebreathing technique without utilizing the test gas. Subjects
then completed a further two ‘‘live’’ maneuver to determine
resting CO before beginning the exercise bouts. Technical
difficulties precluded the recording of CO in two diabetic
participants.
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Statistical analyses. Peak physiological responses
and kinetic parameters were compared at rest and during
exercise among the three groups using a one-way ANOVA
(Sigma Stat, Systat). A two-way repeated-measures ANOVA
(group time) was used to compare cardiac responses during
constant-load cycle exercise bouts. Differences were located
using Tukey post hoc test. Data that were not normally dis-
tributed were analyzed using Kruskal–Wallis test, and multi-
ple comparisons were then performed using Dunn method.
The level of significance was set as P e 0.05. All values are
expressed as mean T SD.
RESULTS
Graded test. Exercise times and peak physiological
responses for the three groups during the graded test are
shown in Table 2. Peak V˙O2 (LImin
j1; mLIkgj1Iminj1) and
the workload at VT were lower in the group with type 2
diabetes compared with the control groups (P G 0.05). The
workload at VT relative to peak workload and peak V˙O2 was
not different among groups (68% T 13% and 78% T 6% type
2 diabetes, 72% T 10% and 77% T 7% heavy controls, and
73% T 10% and 77% T 8% lean controls). In addition, peak
V˙O2 (mLIkg
j1Iminj1) was lower in the heavy control com-
pared with the lean control group (P G 0.05). Peak HR and
peak workload were lower in the group with type 2 diabetes
compared with the lean group but not different compared
with the heavy group (P G 0.05). No differences in peak RER
were observed among the three groups.
Cardiac responses to constant-load exercise.
Cardiac responses obtained at rest and during constant-load
exercise (30 and 240 s) for the three groups and three in-
tensities can be seen in Figure 1. At rest and during exercise
intensities equivalent to 50% VT, cardiac responses were
not different among the three groups. At 80% VT, SV was
higher in subjects with type 2 diabetes at 240 s compared
with the lean and heavy controls (P G 0.05), and the changes
of CO and SV index from 30 to 240 s of exercise were
significantly larger in the group with type 2 diabetes than the
lean and heavy control groups. In addition, the changes of
CI and SV were also larger from 30 to 240 s in the diabetic
compared with the heavy control group. When cycling at
heavy exercise intensities, HR was higher in the lean group
at 240 s compared with both the group with type 2 diabetes
and heavy control group (P G 0.05).
Oxygen uptake and HR kinetic responses to
constant-load exercise. Parameters describing O2 ki-
netics during the three workloads are shown in Table 3. V˙O2
responses during exercise at 50% VT in a diabetic, heavy
control, and lean control subject are shown in Figure 2. The
time constant for the second phase (T2) of the V˙O2 response
was slower in type 2 diabetes compared with the control
groups at intensities relative to 50% VT and 80% VT. The
MRT for V˙O2 was slower in type 2 diabetes compared with
the heavy and lean control groups at 50% VT. MRT was
also slower in type 2 diabetes compared with the heavy
control group, but not the lean control group, at 80% VT.
The time delay for phase 1 (TD1) at 50% VT was greater for
the heavy and lean control groups compared with the group
with type 2 diabetes.
There were no significant differences in parameters that
describe the dynamics of the HR response among these three
groups (type 2 diabetes vs heavy vs lean), at any of the three
intensities, including the time constant (parameter T; 50%
VT = 37.9 T 20.1 vs 25.7 T 11.5 vs 31.2 T 18.5 s; 80% VT =
55.1 T 22.1 vs 36.4 T 17.1 vs 60.3 T 40.1 s; 50% $ = 65.0 T
20.5 vs 68.1 T 15.3 vs 71.0 T 31.5 s).
DISCUSSION
There were two important findings in this study. First,
V˙O2 kinetic responses were slowed during constant-load
cycling exercise at light and moderate exercise intensities
in females with uncomplicated type 2 diabetes compared
with nondiabetic lean and heavy controls, confirming previ-
ous findings (4,7,23). Second, simultaneous measurements of
CO responses at the three constant-load cycling exercise in-
tensities were similar among the three groups, whereas the
change in CO during the period of the fast phase of V˙O2 was
manifest as greater, rather than smaller, in type 2 diabetes
at the moderate intensity. These findings suggest that the
slowing of V˙O2 kinetics in type 2 diabetes is not due to an
impaired response of CO.
Peak oxygen uptake. Subjects with type 2 diabetes
exhibit exercise intolerance (2,20,23,25) that is associated
with an ~20% reduction in peak V˙O2 compared with healthy
subjects of similar age, weight, and activity levels (2,18,
23–25,28). The present findings of a 20% lower peak V˙O2
in the presence of slowed V˙O2 kinetics are in agreement
with other data.
Oxygen uptake kinetics. Understanding the control
of the dynamic response of V˙O2 in diabetes is important as
slowing of this response might be linked to increased fatigue
during exercise and exercise intolerance (13). This V˙O2 re-
sponse consists of at least two to three phases (22). At light
to moderate intensities (GVT), two phases are observed,
whereas at higher intensities above VT and below peak
V˙O2, an additional ‘‘slow’’ phase is manifest (10). The sec-
ond and third of these phases are particularly relevant
TABLE 2. Mean (TSD) peak physiological responses from the graded test for the three
groups of subjects.
Type 2
Diabetes
Heavy
Controls
Lean
Controls
Peak V˙O2 (LImin
j1) 1.40 T 0.26*,** 1.77 T 0.22 1.73 T 0.30
Peak V˙O2 (mLImin
j1Ikgj1) 15.5 T 4.4*,** 22.7 T 2.6* 27.1 T 4.3
Peak HR (bpm) 145 T 20* 165 T 19 173 T 17
Peak Wload (W) 91 T 23* 124 T 28 133 T 34
Wload at VT (W) 61 T 14*
,** 90 T 21 97 T 26
V˙O2 at VT (mLImin
j1Ikgj1) 12.1 T 3.1*,** 17.5 T 2.0 20.9 T 3.5
Peak RER 1.13 T 0.06 1.12 T 0.06 1.10 T 0.08
* Significantly different (P G 0.05) from the lean group.
** Significantly different (P G 0.05) from the heavy group.
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FIGURE 1—CO, cardiac index, SV, stroke volume index, and a-v O2 difference during cycling exercise at 50% VT, 80% VT, and 50% $ in type 2
diabetes, heavy controls, and lean controls. *Significantly different (P G 0.05) from the lean group. †Significantly different (P G 0.05) from the heavy group.
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because they reflect oxygen consumption by active muscle
(11). Accurate interpretation of the effect of type 2 diabetes
on the dynamic response of V˙O2 depends on an accurate
description of these phases. Inaccurate description of the
structure of a dynamic response (e.g., the number of phases)
leads to large errors in estimating time constants and errone-
ous conclusions about the ‘‘kinetics’’ of the response (21).
A limitation with two of the three previous studies of V˙O2
kinetics in type 2 diabetes (7,23) is the assumption that the
V˙O2 response during a 3- to 6-min bout of submaximal ex-
ercise was monophasic. Although a larger time constant of
this single-phase response was observed at low and moderate
intensities in type 2 diabetes (7,23), suggesting that the
overall V˙O2 response is slowed, the real response is at least
biphasic, and so it is not clear which of these two phases is
slowed.
In the present study, biphasic and triphasic functions were
fitted to responses at low to moderate and high intensities,
respectively. At the low and moderate intensity, a larger time
constant for phase 2 of the V˙O2 response in type 2 diabetes
clearly demonstrates a slowing of the ‘‘kinetic’’ response of
this phase. This is consistent with more recent evidence of a
slowing of phase 2 at an intensity below the ‘‘lactate thresh-
old’’ (4). Collectively, these data show that the slowed ad-
justment of V˙O2 during the early period of exercise in type
2 diabetes, represented by a larger mean response time, is
focused on phase 2. Because this phase is attributed almost
entirely to O2 consumption by contracting muscle (11), these
data confirm that type 2 diabetes results in a slowing of the
initial adjustment of muscle V˙O2 during exercise.
However, at the highest intensity, the time constant of
phase 2 was similar among the three groups. This is also
consistent with earlier evidence of no slowing of the overall
V˙O2 response (monophasic) in type 2 diabetes at a relatively
high intensity (23). In the absence of other physiological
data, this intensity-dependent effect of type 2 diabetes on
V˙O2 kinetics is difficult to explain.
Mechanisms for the slowed oxygen uptake
kinetics. On the basis of the Fick equation for V˙O2,
the control of V˙O2 depends on the control of blood flow
and a-v O2. Blood flow could be limited by poor pumping
capacity and/or impaired vasodilation, whereas a-v O2 reflects
an interaction between blood flow and myocyte V˙O2, where
the latter can be impaired by metabolic inertia (16).
CO responses in diabetic subjects have been shown to be
similar to nondiabetic subjects after 5 min of submaximal
cycling (2). However, before the present study, no data de-
scribing the rate of adjustment of CO before these responses
plateauing during steady-state exercise were available. In
addition, this is the first time where V˙O2 kinetics and CO
responses have been measured simultaneously in the same
subjects during the same exercise protocols. The present
findings found no differences in CO between groups at any
time point during exercise, and HR kinetics were also sim-
ilar. In addition, the change in CO from the onset (30 s) to
240 s of exercise was significantly greater, and not lower, at
moderate intensities in the group with type 2 diabetes com-
pared with the two nondiabetic control groups. Because this
period is closely associated with phase 2 of the V˙O2 re-
sponse, these findings suggest that the slowed V˙O2 response
is not due to a slow adjustment of CO.
The dynamic response of V˙O2 might be impaired by a
slowing of the rise in O2 consumption by contracting mus-
cle, resulting in a slower increase in a-v O2. In support of
this is evidence of a lower mitochondrial content (27) and
abnormal mitochondrial function (15,27) in skeletal muscle
of subjects with type 2 diabetes compared with healthy
controls. However, in the present study, the a-v O2 was not
different during any of the three submaximal exercise in-
tensities investigated between type 2 diabetes and nondia-
betic controls. In addition, the changes in a-v O2 difference
from rest to the onset of exercise (30 s) and from 30 to 240 s
of exercise were not different between groups (Fig. 1). This
suggests that the ability of active muscle to extract O2 during
exercise might not be impaired in type 2 diabetes. Our
findings support the results by Baldi et al. (2), who also
reported similar a-v O2 responses after 5 min of submaximal
cycling in diabetic and nondiabetic subjects.
In the absence of any apparent cardiac dysfunction and
similar a-v O2 responses, it is likely that the slowed V˙O2
TABLE 3. Mean (TSD) dynamic response characteristics of oxygen uptake during
cycling exercise at 50% VT, 80% VT, and 50% $ in type 2 diabetes, heavy controls, and
lean controls.
Type 2 Diabetes Heavy Controls Lean Controls
50% VT
Baseline V˙O2 (LImin
j1) 0.34 T 0.09 0.29 T 0.06 0.28 T 0.10
A1 (LImin
j1) 0.30 T 0.12 0.29 T 0.16 0.33 T 0.11
TD1 (s) 2.3 T 3.3 3.7 T 4.5 5.1 T 3.9
T1 (s) 5.9 T 3.4 5.0 T 4.7 5.5 T 3.8
A2 (LImin
j1) 0.34 T 0.12 0.30 T 0.11 0.34 T 0.10
TD2 (s) 36.0 T 12.4 27.4 T 11.1 32.5 T 8.7
T2 (s) 34.2 T 15.7*
,** 15.4 T 7.3 20.2 T 9.7
A420 (LImin
j1) 0.98 T 0.22 0.88 T 0.16 0.95 T 0.24
MRT (s) 40.7 T 9.2*,** 25.6 T 6.6 32.1 T 5.2
80% VT
Baseline V˙O2 (LImin
j1) 0.33 T 0.09 0.31 T 0.08 0.31 T 0.11
A1 (LImin
j1) 0.31 T 0.12 0.41 T 0.12 0.44 T 0.15
TD1 (s) 1.4 T 2.1* 5.0 T 3.5 6.0 T 4.6
T1 (s) 5.0 T 5.4 3.5 T 1.7 6.6 T 2.6
A2 (LImin
j1) 0.51 T 0.15 0.47 T 0.20 0.49 T 0.22
TD2 (s) 23.9 T 8.8 30.8 T 8.9 32.5 T 10.6
T2 (s) 39.1 T 9.0*
,** 24.8 T 8.8 26.8 T 10.4
A420 (LImin
j1) 1.16 T 0.19 1.19 T 0.22 1.24 T 0.32
MRT (s) 41.1 T 5.9** 33.2 T 4.5 36.8 T 7.9
50% $
Baseline V˙O2 (LImin
j1) 0.33 T 0.08 0.32 T 0.05 0.35 T 0.13
A1 (LImin
j1) 0.42 T 0.15 0.49 T 0.11 0.47 T 0.09
TD1 (s) 4.8 T 6.2 7.0 T 5.4 5.0 T 4.0
T1 (s) 6.5 T 5.0 5.5 T 4.6 8.5 T 6.2
A2 (LImin
j1) 0.56 T 0.32 0.65 T 0.24 0.84 T 0.27
TD2 (s) 33.4 T 10.0 32.0 T 8.7 26.8 T 14.0
T2 (s) 22.1 T 12.2 21.1 T 6.2 24.1 T 10.2
A3 (LImin
j1) 0.14 T 0.05 0.14 T 0.06 0.19 T 0.09
TD3 (s) 140.0 T 33.0 141.6 T 38.2 148.4 T 23.3
T3 (s) 139.9 T 167.8 83.2 T 65.0 84.6 T 45.0
A420 (LImin
j1) 1.48 T 0.33 1.60 T 0.28 1.71 T 0.39
MRT (s) 65.4 T 24.8 56.7 T 15.6 61.2 T 11.9
See Methods for further description.
* Significantly different (P G 0.05) from the lean group.
* Significantly different (P G 0.05) from the heavy group.
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kinetic responses are, at least in part, linked to a maldistri-
bution and/or slowed dynamic adaptations of blood flow to
the active muscles. The latter is supported by observations of
significantly lower limb blood flow responses after several
minutes of submaximal cycling in uncomplicated type 2 di-
abetes (17). This would help explain the more rapid decline in
muscle microvascular PO2 observed in diabetic rats compared
with control rats (6) and the transient ‘‘overshoot’’ in NIRS-
measured [HHb] at the onset of cycling exercise above the
steady-state levels in humans with uncomplicated type 2 di-
abetes. (4). Collectively, these findings suggest that the rate of
O2 delivery is slowed relative to the rate of O2 consumption
by the active muscles in type 2 diabetes. However, steady-
state blood flow measurements (17) do not demonstrate the
dynamic adaptations before these responses, and thus, further
studies are needed to explore if muscle blood flow kinetics
are altered in diabetes.
The present findings are clinically important. The slower
O2 uptake adaptations to light–moderate exercise intensities
in diabetes imply a greater reliance on anaerobic metabolism
leading to more rapid fatigue and a lowering of exercise tol-
erance. These effects might contribute to the perception of
daily light routine activities (i.e., climbing stairs, etc.) as be-
ing more difficult, as observed in uncomplicated type 2 dia-
betes (12), and they might reduce the willingness to adopt
a more active lifestyle.
Limitations. Previous diabetic women studied in regard
to V˙O2 kinetics were premenopausal (4,7,23). In contrast, in
the present study, both premenopausal and postmenopausal
women were studied and menopause may affect exercise
responses by reducing endothelial-dependent vasodilation
(29). However, this is unlikely to have introduced bias in the
results given that the distribution of premenopausal and
postmenopausal women was similar in the three groups. The
BMI values were numerically larger (although not signifi-
cantly different) in subjects with type 2 diabetes compared
with heavy controls. It is unlikely that these differences in
BMI affected our results given that ‘‘obesity’’ per se did not
alter exercise responses among nondiabetic lean and heavy
participants. The peak V˙O2 during the incremental test was
numerically lower (but not significantly different) than the
V˙O2 at the end of the high-intensity constant-load test in the
diabetic participant. Although others have also reported
these responses (23), these data might question whether the
incremental test evoked ‘‘peak’’ or maximal responses in
diabetic participants. Although only two of the nine diabetic
subjects reached their predicted maximum HR, eight of the
nine subjects reached peak RER values in excess of 1.1, and
their V˙O2 values increased G2 mLIkg
j1Iminj1 with an in-
crease in work rate (i.e., eight of nine diabetic participants
reached V˙O2max (9)). Thus, we are confident that diabetic
participants reached maximal responses.
CONCLUSIONS
In summary, these findings confirm that exercise toler-
ance and the dynamic response of oxygen uptake during
low to moderate exercise are impaired in type 2 diabetes.
These effects, however, are not related to CO because its
response during exercise was not slower or smaller in type 2
diabetes. These findings are limited to females with un-
complicated type 2 diabetes, and further research is required
FIGURE 2—Representative oxygen uptake responses during cycling exercise at intensities equivalent to 50% VT in an individual with type 2
diabetes, a heavy control, and a lean control. The individual with type 2 diabetes has a slower T2 and MRT (T2 = 56.2 s, MRT = 48.1 s) than the
heavy control (T2 = 17.1 s, MRT = 30.1 s) and lean control (T2 = 16.9 s, MRT = 32.4 s).
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to establish the influence of CO on exercise V˙O2 when
comorbidities are present and in male subjects with type 2
diabetes.
Oscar Mac Ananey and John Malone equally contributed to this
work. This research has not received any external funding.
The results of the present study do not constitute endorsement
by the American College of Sports Medicine.
REFERENCES
1. Amann M, Subudhi A, Foster C. Influence of testing protocol on
ventilatory thresholds and cycling performance. Med Sci Sports
Exerc. 2004;36(4):613–22.
2. Baldi JC, Aoina JL, Oxenham HC, Bagg W, Doughty RN. Re-
duced exercise arteriovenous O2 difference in Type 2 diabetes.
J Appl Physiol. 2003;94:1033–8.
3. Barstow TJ, Jones AM, Nguyen PH, Casaburi R. Influence of
muscle fiber type and pedal frequency on oxygen uptake kinetics
of heavy exercise. J Appl Physiol. 1996;81:1642–50.
4. Bauer TA, Reusch JE, Levi M, Regensteiner JG. Skeletal muscle
deoxygenation after the onset of moderate exercise suggests
slowed microvascular blood flow kinetics in type 2 diabetes. Dia-
betes Care. 2007;30:2880–5.
5. Beaver WL, Wasserman K, Whipp BJ. A new method for detect-
ing anaerobic threshold by gas exchange. J Appl Physiol. 1986;60:
2020–7.
6. Behnke BJ, Kindig CA, McDonough P, Poole DC, Sexton WL.
Dynamics of microvascular oxygen pressure during rest–contraction
transition in skeletal muscle of diabetic rats. Am J Physiol Heart
Circ Physiol. 2002;283:H926–32.
7. Brandenburg SL, Reusch JE, Bauer TA, Jeffers BW, Hiatt WR,
Regensteiner JG. Effects of exercise training on oxygen uptake
kinetic responses in women with type 2 diabetes. Diabetes Care.
1999;22:1640–6.
8. Burnley M, Doust JH, Jones AM. Time required for the restoration
of normal heavy exercise V˙O2 kinetics following prior heavy ex-
ercise. J Appl Physiol. 2006;101:1320–7.
9. Carter H, Jones AM, Barstow TJ, Burnley M, Williams CA,
Doust JH. Oxygen uptake kinetics in treadmill running and cycle
ergometry: a comparison. J Appl Physiol. 2000;89:899–907.
10. Gaesser GA, Poole DC. The slow component of oxygen uptake
kinetics in humans. Exerc Sport Sci Rev. 1996;24:35–71.
11. Grassi B, Poole DC, Richardson RS, Knight DR, Erickson BK,
Wagner PD. Muscle O2 uptake kinetics in humans: implications
for metabolic control. J Appl Physiol. 1996;80:988–98.
12. Huebschmann AG, Reis EN, Emsermann C, et al. Women with
type 2 diabetes perceive harder effort during exercise than non-
diabetic women. Appl Physiol Nutr Metab. 2009;34:851–7.
13. Hughson RL, Tschakovsky ME, Houston ME. Regulation of ox-
ygen consumption at the onset of exercise. Exerc Sport Sci Rev.
2001;29(3):129–33.
14. Jakovljevic DG, Nunan D, Donovan G, Hodges LD, Sandercock
GR, Brodie DA. Comparison of cardiac output determined by
different rebreathing methods at rest and at peak exercise. Eur J
Appl Physiol. 2008;102:593–9.
15. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mi-
tochondria in human skeletal muscle in type 2 diabetes. Diabetes.
2002;51:2944–50.
16. Kindig CA, Howlett RA, Stary CM, Walsh B, Hogan MC. Effects
of acute creatine kinase inhibition on metabolism and tension de-
velopment in isolated single myocytes. J Appl Physiol. 2005;98:
541–9.
17. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell
GK. Type 2 diabetic individuals have impaired leg blood flow
responses to exercise: role of endothelium-dependent vasodilation.
Diabetes Care. 2003;26:899–904.
18. Kjaer M, Hollenbeck CB, Frey-Hewitt B, Galbo H, Haskell W,
Reaven GM. Glucoregulation and hormonal responses to maximal
exercise in non–insulin-dependent diabetes. J Appl Physiol. 1990;
68:2067–74.
19. Kriska AM, Edelstein SL, Hamman RF, et al. Physical activity in
individuals at risk for diabetes: Diabetes Prevention Program. Med
Sci Sports Exerc. 2006;38(5):826–32.
20. Lalande S, Gusso S, Hofman PL, Baldi JC. Reduced leg blood
flow during submaximal exercise in type 2 diabetes.Med Sci Sports
Exerc. 2008;40(4):612–7.
21. Lamarra N. Variables, constants, and parameters: clarifying the
system structure. Med Sci Sports Exerc. 1990;22(1):88–95.
22. Ozyener F, Rossiter HB, Ward SA, Whipp BJ. Influence of exer-
cise intensity on the on- and off-transient kinetics of pulmonary
oxygen uptake in humans. J Physiol. 2001;533:891–902.
23. Regensteiner JG, Bauer TA, Reusch JE, et al. Abnormal oxygen
uptake kinetic responses in women with type II diabetes mellitus.
J Appl Physiol. 1998;85:310–7.
24. Regensteiner JG, Bauer TA, Reusch JE, et al. Cardiac dysfunction
during exercise in uncomplicated type 2 diabetes. Med Sci Sports
Exerc. 2009;41(5):977–84.
25. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR.
Effects of non–insulin-dependent diabetes on oxygen consumption
during treadmill exercise.Med Sci Sports Exerc. 1995;27(6):875–81.
26. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves
functional status in patients with peripheral arterial disease. J Vasc
Surg. 1996;23:104–15.
27. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH,
Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity
and type 2 diabetes. Diabetes. 2005;54:8–14.
28. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB.
Studies on the mechanism of improved glucose control during
regular exercise in type 2 (non–insulin-dependent) diabetes. Dia-
betologia. 1984;26:355–60.
29. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated
with endothelial dysfunction in women. Hypertension. 1996;28:
576–82.
30. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN.
Low cardiorespiratory fitness and physical inactivity as predic-
tors of mortality in men with type 2 diabetes. Ann Intern Med.
2000;132:605–11.
31. Wilkerson DP, Koppo K, Barstow TJ, Jones AM. Effect of work
rate on the functional ‘‘gain’’ of phase II pulmonary O2 uptake
response to exercise. Respir Physiol Neurobiol. 2004;142:211–23.
http://www.acsm-msse.org942 Official Journal of the American College of Sports Medicine
C
LI
N
IC
A
L
SC
IE
N
C
ES
Copyright © 2011 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
